Is BHC Worth Buying in 2026?

Bausch Health Companies Inc

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-08-16

Here’s whether Bausch Health Companies Inc (BHC) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+4.10% over 10 days); 3-month momentum positive (+20.1%); rising volume confirms the move (1.20x 30d avg). Concerns: RSI 73 — overbought, elevated pullback risk; weak 1-year return of -13.3%. Currently 25.0% off its 52-week high. Score: +4/7.

Ready to act on this? 📈 Trade on Webull

BHC is in a confirmed uptrend, trading above both its 50-day ($5.22) and 200-day ($5.85) moving averages. With an RSI of 72.6, momentum has stretched into overbought territory — short-term pullbacks are common from these levels. The 1-year return of -13.3% compares to +20.4% for SPY (trailed the market by 33.7%). The current 25.0% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $8,668 today
vs. S&P 500 (SPY) — same period trailed market by 33.7%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($5.85)
Above 50-day MA ($5.22)
!RSI(14) neutral zone (30–70) — currently 72.6
Positive return (-13.3%)
!Within 10% of period high (−25.0%)
Period Range $6.51
$4.33 $8.69
RSI (14) 72.6
0 · OversoldOverbought · 100

Key Metrics

Price$6.51
Period Return-13.3%
Period High$8.69
Period Low$4.33
Drawdown−25.0%
MA-50$5.22
MA-200$5.85
RSI (14)72.6
Avg Volume (30d)4.1M
vs. SPYtrailed by 33.7%
Return Rank#815 of 1252

Trade BHC

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers